T
T. Wagener
Researcher at University of Western Ontario
Publications - 11
Citations - 695
T. Wagener is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Bone Sarcoma & Soft tissue sarcoma. The author has an hindex of 8, co-authored 11 publications receiving 683 citations.
Papers
More filters
Journal ArticleDOI
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Vivien H.C. Bramwell,Jacques Rouëssé,William P. Steward,Armando Santoro,H Schraffordt-Koops,J. Buesa,W. Ruka,J Priario,T. Wagener,M Burgers +9 more
TL;DR: Adjuvant chemotherapy with CYVADIC cannot be recommended outside the context of a clinical trial, and experience from this study has been used to plan a trial of neoadjuant chemotherapy with doxorubicin/ifosfamide, which is currently in progress.
Journal ArticleDOI
Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group
Herbert M. Pinedo,Vivien H.C. Bramwell,H. T. Mouridsen,R. Somers,C. P. J. Vendrik,Armando Santoro,J. Buesa,T. Wagener,A. van Oosterom,J. A. M. van Unnik,Richard Sylvester,M. De Pauw,D. Thomas,O. Bonadonna +13 more
TL;DR: In this paper, a large number of adults with advanced progressive soft tissue sarcoma received combination chemotherapy with cyclophosphamide, vincristine, Adriamycin (doxorubicin), and DTIC.
High-dose DTIC in advanced soft-tissue sarcomas in the adult
J. Buesa,Henning T. Mouridsen,A.T. van Oosterom,Jaap Verweij,T. Wagener,W.P. Steward,Andres Poveda,P. M. Vestlev,D. Thomas,Richard Sylvester +9 more
Journal ArticleDOI
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.
J. Buesa,Henning T. Mouridsen,A. van Oosterom,Jaap Verweij,T. Wagener,W.P. Steward,Andres Poveda,P. M. Vestlev,D. Thomas,Richard Sylvester +9 more
TL;DR: Intermittent high-dose DTIC is active in advanced soft-tissue sarcoma and should be considered for inclusion in combination regimens.
Journal ArticleDOI
Osteosarcoma of the limbs: report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation
J. M. V. Burgers,M. van Glabbeke,A. Busson,P. Cohen,André Mazabraud,J. S. Abbatucci,Chantal Kalifa,M. Tubiana,Jean Lemerle,P. A. Voǔte,A. van Oosterom,A. Pons,T. Wagener,B. van der Werf-Messing,R. Somers,Nicole Duez +15 more
TL;DR: The European Organization for Research on Treatment of Cancer (EORTC) trial 20781, concerning osteosarcoma of the limbs, provided the same survival as the adjuvant chemotherapy given in that time.